NVS
Novartis AG
Stock
$141.00−0.05 (−0.04%)Close Oct 2, 2026
Cash flow statement
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $19.1B | $17.6B | $14.5B | $14.2B | $15.1B | $13.7B | $13.6B | $14.3B | $12.6B | $11.5B |
| Capital expenditures | $1.5B | $1.4B | $1.1B | $916M | $1.1B | $1.3B | $1.4B | $1.3B | $1.3B | $1.9B |
| Free cash flow | $17.6B | $16.3B | $13.4B | $13.3B | $14.0B | $12.4B | $12.2B | $13.0B | $11.3B | $9.6B |
| Stock-based compensation | $1.1B | $1.0B | $865M | $791M | $700M | $738M | $758M | $673M | $612M | $671M |
| Buybacks | $9.2B | $8.3B | $8.7B | $10.7B | $3.1B | $2.8B | $5.5B | $2.0B | $5.5B | $1.1B |
| Dividends paid | $7.8B | $7.6B | $7.3B | $7.5B | $7.4B | $7.0B | $6.6B | $7.0B | $6.5B | $6.5B |